Can Semaglutide Mess With Your Period?

You notice your period is different three weeks into treatment, here is the most likely reason why

Picture this: you are a few weeks into Wegovy, eating less, and your body is shifting weight noticeably for the first time in years. Then your period arrives early, or is a week late, or feels lighter than usual. The instinct is to wonder whether the injection caused it. The honest answer is: probably indirectly, and through a well-understood mechanism.

Fat tissue is not just storage, it produces and converts oestrogens. When body fat decreases meaningfully, circulating oestrogen levels change, and that can be enough to nudge the timing and character of your cycle. The hypothalamic-pituitary-ovarian axis, which governs when you ovulate, is sensitive to energy balance and body composition. A shift of even five to ten percent of body weight can be enough to alter cycle length. This is the same biology that underpins why athletes with very low body fat sometimes lose periods altogether, and why women who gain weight after menopause notice hormonal effects.

Semaglutide, the active ingredient in Wegovy, works by reducing appetite and slowing how quickly the stomach empties. It does not target ovarian function or reproductive hormones directly. The NHS medicines page for semaglutide lists the recognised side effects in detail; disruption to menstruation does not appear there as a direct effect. What does appear, consistently, is that weight loss of the scale semaglutide produces in clinical trials will have downstream effects on metabolism and hormones, and the cycle sits inside that system.

A shorter or longer cycle by a few days, or one heavier period during early weight loss, is generally something to monitor rather than panic about. If you want a fuller picture of exactly what to expect, our dedicated page on semaglutide and your period covers the patterns in more detail. Worth keeping a note of dates so the pattern becomes clear.

When PCOS is part of the picture, semaglutide's effect on your period can actually be positive

For women with polycystic ovary syndrome, the relationship between weight and cycle regularity is tightly wound. Excess weight raises insulin levels and drives androgen production, which is one of the key mechanisms behind irregular or absent periods in PCOS. Losing weight (through any sustained method) often brings cycles back towards regularity, and some women find this happens noticeably during treatment with semaglutide.

Clinical observations from the STEP trial programme, and from real-world prescribing since Wegovy became available, include reports of women with PCOS regaining more predictable cycles as their weight falls. This is not an approved indication, and semaglutide is not prescribed as a fertility treatment. It is a side effect of weight loss that happens to be welcome. Our clinical team sees this pattern discussed regularly in consultations.

The complication this creates is worth naming plainly: a more regular cycle can mean ovulation is returning, and ovulation means fertility. Women who had assumed PCOS made conception unlikely may find that assumption no longer holds during treatment. Contraception matters here. The NHS England guidance on weight-management injections specifically addresses contraception, and it is not a topic to skim past.

If you have been using your irregular periods as a form of contraceptive reasoning, that reasoning should be revisited with your GP or prescriber as soon as you start a GLP-1 treatment.

Oral contraceptives, absorbed less reliably, what your prescriber needs you to know

There is a practical wrinkle with the combined pill that applies specifically to tirzepatide (Mounjaro), but understanding the mechanism is useful context for semaglutide too. Semaglutide slows gastric emptying, which means tablets spend longer in the stomach. For most medicines, the clinical significance of this is small. For time-sensitive oral contraceptives, taken daily at a specific window, the concern is whether the slowed transit affects absorption consistently.

The evidence base here is still developing. Current UK guidance, including notes from NHS Scotland's diabetes and weight-loss medication page, advises discussing contraception with a clinician when starting a GLP-1 medicine. For tirzepatide specifically, adding a barrier method for the first four weeks and after each dose increase is recommended. Semaglutide does not carry the identical instruction in UK guidance, but the principle of discussing your contraceptive method with your prescriber remains sound.

If you are exploring what a private semaglutide consultation looks like, the treatment overview at nume sets out what the process involves. Contraception is one of the topics our prescribers cover during that assessment, it is a standard part of the clinical conversation, not an afterthought.

If you take the pill and you start Wegovy around a busy stretch (say, a holiday or a bank holiday week when you might forget to pack extra contraception) plan ahead. A missed pill window during a period of reduced absorption reliability is a gap worth closing before it opens.

A missed period on semaglutide: when to act and what to rule out first

A single late or missed period during the first months of treatment is common enough that it should not be alarming on its own. But it should not be brushed off either. The first thing to rule out, always, is pregnancy. This is especially true for women who had irregular cycles before starting treatment, whose fertility may have shifted as weight has begun to change.

If a pregnancy test is negative and periods remain disrupted after two or three cycles, that is the point to loop in your GP. Thyroid function, iron levels and stress are among the non-semaglutide explanations worth checking. Treatment with a GLP-1 medicine does not occur in a vacuum, and a prescriber who can see your Summary Care Record is better placed to spot if something else is contributing.

If you want to understand more about the broader question of whether semaglutide can stop a period entirely, the dedicated page on whether semaglutide stops your period covers that in more depth. For questions specifically about timing (whether a period arriving later than usual is linked to treatment) the page on semaglutide and a late period addresses those scenarios directly.

Semaglutide is a prescription-only medicine. If period changes are worrying you during treatment, a same-day conversation with our prescribers is part of what aftercare at nume is for. You can also find broader context about what Wegovy involves on our Wegovy treatment page. If you are still weighing up whether to start, and want to understand how Fitaro semaglutide fits into the range of options available, that page explains the differences before you commit to anything. Starting a free consultation is how that conversation begins.